AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
AXIM BIOTECHNOLOGIES, INC.
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Axim Biotechnologies's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Catalina Valencia President and Director, 10% owner | Jan 30, 2024 | Buy | +1,086,216 | – | – | 28,608,220 |
| Catalina Valencia 10% owner | Aug 24, 2022 | Buy | +3,861,004 | $0.03 | $115.83K | 23,661,004 |
| Blake Schroeder Director | Aug 22, 2022 | Conversion | +854,012 | $0.03 | $25.62K | 854,012 |
| John Walter Huemoeller Ii Chief Executive Officer, Director | Mar 19, 2020 | Buy | +6,000,000 | – | – | 6,000,000 |
| Robert Malasek CFO | Mar 21, 2018 | Award | +50,000 | – | – | 50,000 |
| Marijuana Inc Medical 10% owner | Dec 2, 2016 | Award | +7,200,000 | – | – | 22,669,125 |
| Marijuana Inc Medical 10% owner | Dec 2, 2016 | Award | +7,200,000 | – | – | 22,143,650 |
| Marijuana Inc Medical 10% owner | Nov 21, 2016 | Award | +500,000 | – | – | 500,000 |
| Lekhram Changoer Director, 10% owner | Nov 21, 2016 | Award | +240,000 | – | – | 2,265,000 |
| Lekhram Changoer Director, 10% owner | Nov 21, 2016 | Award | +500,000 | – | – | 500,000 |
| Lekhram Changoer Director, 10% owner | Nov 21, 2016 | Award | +2,000,000 | – | – | 2,265,000 |
| Marijuana Inc Medical 10% owner | Nov 21, 2016 | Award | +500,000 | – | – | 500,000 |
| George Anastassov CEO/Secretary, Director, 10% owner | Nov 21, 2016 | Award | +500,000 | – | – | 500,000 |
| George Anastassov CEO/Secretary, Director, 10% owner | Nov 21, 2016 | Award | +2,000,000 | – | – | 3,002,000 |
| George Anastassov CEO/Secretary, Director, 10% owner | Nov 21, 2016 | Award | +250,000 | – | – | 3,002,000 |
| George Anastassov President, Director, 10% owner | Feb 5, 2016 | Award | +125,000 | – | – | 15,365,650 |
| Lekhram Changoer Director, 10% owner | Dec 18, 2015 | Award | +25,000 | – | – | 25,000 |
| George Anastassov President, Director, 10% owner | Nov 9, 2015 | Award | +125,000 | – | – | 15,240,650 |
| George Anastassov President, Director, 10% owner | Jul 2, 2015 | Award | +500,000 | – | – | 15,240,650 |
| Lekhram Changoer Director, 10% owner | Apr 23, 2015 | Award | +1,000,000 | – | – | 1,500,000 |
| George Anastassov President, Director, 10% owner | Apr 23, 2015 | Award | +1,000,000 | – | – | 1,500,000 |
| George Anastassov President, Director, 10% owner | Feb 23, 2015 | Award | +2,000 | – | – | 14,945,650 |
| Rosemary Samuels PRESIDENT, CEO, CFO, Director, 10% owner | Mar 21, 2014 | Sale | −1,000,000 | $400.00 | $400.00M | 0 |
| Rosemary Samuels PRESIDENT, CEO, CFO, Director, 10% owner | Mar 21, 2014 | Sale | −20,000,000 | $8000.00 | $160.00B | 0 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.